title: The effect of post-transplant spironolactone on daily potassium requirements in patients undergoing autologous stem cell transplantation.
authors.forename: T
authors.initials: T
authors.lastname: Demirer
authors.forename: M
authors.initials: M
authors.lastname: Ayli
authors.forename: M
authors.initials: M
authors.lastname: Dagli
authors.forename: T
authors.initials: T
authors.lastname: Fen
authors.forename: R
authors.initials: R
authors.lastname: Haznedar
authors.forename: N
authors.initials: N
authors.lastname: Ustael
authors.forename: T
authors.initials: T
authors.lastname: Ustun
authors.forename: A
authors.initials: A
authors.lastname: Oymak
authors.forename: O
authors.initials: O
authors.lastname: Ozdel
authors.forename: O
authors.initials: O
authors.lastname: Muftuoglu
mesh_terms: D000293:Adolescent; D000328:Adult; D004232:Diuretics / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007008:Hypokalemia / Q000188:drug therapy / Q000209:etiology; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications / Q000628:therapy; D036102:Peripheral Blood Stem Cell Transplantation / Q000009:adverse effects*; D011188:Potassium / Q000008:administration & dosage* / Q000097:blood; D013148:Spironolactone / Q000008:administration & dosage / Q000494:pharmacology*; D014182:Transplantation, Autologous
chemical_list: D004232:Diuretics; D013148:Spironolactone; D011188:Potassium